 |
|
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies
Verdiana Ravarotto, Giovanni Bertoldi, Lucia Federica Stefanelli, Federico Nalesso, Lorenzo A. Calò
Kidney Res Clin Pract. 2022;41(5):533-544. Published online 2022 Sep 30 DOI: https://doi.org/10.23876/j.krcp.22.069
|
|
Citations to this article as recorded by
 Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study
Cheol Ho Park, Hyung Woo Kim, Jung Tak Park, Tae Ik Chang, Tae-Hyun Yoo, Sue Kyung Park, Kyu Beck Lee, Ji Yong Jung, Jong Cheol Jeong, Kook-Hwan Oh, Shin-Wook Kang, Seung Hyeok Han
Atherosclerosis.2024; 395: 117563. CrossRef The impacts of dietary antioxidants on cardiovascular events in hemodialysis patients: An update on the cellular and molecular mechanisms
Sepideh Zununi Vahed, Seyyedeh Mina Hejazian, Mohammadreza Ardalan, Fani Anagnostou, Graciela Pavon-Djavid, Abolfazl Barzegari
Nutrition Reviews.2024;[Epub] CrossRef Oxidative stress reduction by icodextrin‐based glucose‐free solutions in peritoneal dialysis: Support for new promising approaches
Anna Basso, Paola Baldini, Giovanni Bertoldi, Giulia Driussi, Ilaria Caputo, Elisabetta Bettin, Martina Cacciapuoti, Lorenzo A. Calò
Artificial Organs.2024; 48(9): 1031. CrossRef Oxidative stress and its role in Fabry disease
Martina Cacciapuoti, Giovanni Bertoldi, Ilaria Caputo, Giulia Driussi, Gianni Carraro, Lorenzo A. Calò
Journal of Nephrology.2024; 37(5): 1201. CrossRef Dose and Time Effects of Renin–Angiotensin Inhibitors on Patients With Advanced Stages 4 to 5 of Diabetic Kidney Disease
Yi-Chun Chen, Chien-Hsueh Tung, Ben-Hui Yu
Journal of the Endocrine Society.2024;[Epub] CrossRef Interplay between periodontitis and chronic kidney disease
Iain L. C. Chapple, Josefine Hirschfeld, Paul Cockwell, Thomas Dietrich, Praveen Sharma
Nature Reviews Nephrology.2024;[Epub] CrossRef Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
Giovanni Bertoldi, Ilaria Caputo, Giulia Driussi, Lucia Federica Stefanelli, Valentina Di Vico, Gianni Carraro, Federico Nalesso, Lorenzo A. Calò
Journal of Clinical Medicine.2023; 12(5): 2063. CrossRef Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes
Luca Sgarabotto, Verdiana Ravarotto, Lucia Federica Stefanelli, Martina Cacciapuoti, Paul A. Davis, Federico Nalesso, Lorenzo A. Calò
Antioxidants.2023; 12(4): 811. CrossRef Sarcopenia in chronic kidney disease: from bench to bedside
Da Woon Kim, Sang Heon Song
The Korean Journal of Internal Medicine.2023; 38(3): 303. CrossRef Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
Chan Ho Kim, Hye-Young Kang, Gyuri Kim, Jimin Park, Bo Young Nam, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Frontiers in Pharmacology.2023;[Epub] CrossRef Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease
Sang Min Jo
Electrolytes & Blood Pressure.2023; 21(1): 24. CrossRef The RAAS Goodfellas in Cardiovascular System
Ilaria Caputo, Giovanni Bertoldi, Giulia Driussi, Martina Cacciapuoti, Lorenzo A. Calò
Journal of Clinical Medicine.2023; 12(21): 6873. CrossRef
|